Not using Bio­strength for BE [Regulatives / Guidelines]

posted by jag009  – NJ, 2018-07-17 06:32 (867 d 07:18 ago) – Posting: # 19073
Views: 1,768


» Our firm is developing a multi-strength product which is a high potency, NTI oral dosage...

1) Is 0.15mg your only strength?
2) Why you want to dose 0.15x4 and not just 0.15mg?
3) Better to file a control correspondence


Complete thread:

 Admin contact
21,223 posts in 4,427 threads, 1,481 registered users;
online 31 (1 registered, 30 guests [including 12 identified bots]).
Forum time: Monday 12:51 CET (Europe/Vienna)

It’s difficult to work in a group
when you are omnipotent.    John de Lancie (as Q)

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz